Five-year Outcomes of Ranibizumab in Neovascular Age-related Macular Degeneration: Real Life Clinical Experience

PURPOSE: To evaluate the outcomes of 5-year ranibizumab treatment in neovascular age-related macular degeneration (nAMD) in a single center and real life clinical setting. METHODS: The records of nAMD patients who were treated with ranibizumab between January 2010 and June 2011 were retrospectively...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Korean J Ophthalmol
Egile Nagusiak: Ozkaya, Abdullah, Alkin, Zeynep, Togac, Mesut, Ahmet, Sibel, Perente, Irfan, Taskapili, Muhittin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Korean Ophthalmological Society 2017
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5636718/
https://ncbi.nlm.nih.gov/pubmed/28913999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3341/kjo.2016.0125
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak